Metabolic modulation

Metabolic modulation refers to the therapeutic strategy of influencing cellular metabolic pathways in order to treat diseases characterized by disrupted metabolism, such as cancer, diabetes, and cardiovascular disorders[1][2][4][5][8]. This approach targets multiple metabolic enzymes and regulatory proteins involved in processes like glucose metabolism, lipid metabolism, and energy homeostasis. Key pathway modulators include enzymes (e.g., pyruvate dehydrogenase, lactate dehydrogenase), regulatory kinases (e.g., AMPK, mTOR), and nuclear hormone receptors (e.g., PPARs)[2][5]. The objective is to restore normal cellular metabolism, correct imbalances, and alter cell fate decisions, often by either reprogramming metabolic flux or providing necessary nutritional cofactors[1]. "Metabolic modulation" itself is not a distinct molecular entity but an umbrella term for strategies to therapeutically alter metabolic processes through various molecular targets, drugs, and interventions. This target entry is marked as "incorrect" because "Metabolic modulation" is not a specific molecule, receptor, or canonical therapeutic target, but rather a high-level mechanistic concept or strategy.

Modulation of metabolic enzyme activity (activation or inhibition)[5]; Alteration of metabolic pathway flux (e.g., shifting balance between glycolysis and oxidative phosphorylation)[1][5]; Regulation of cell fate via metabolic reprogramming (e.g., apoptosis, ferroptosis, proliferation)[8]; Control of cellular energy balance and resource allocation[1][5][8]